222 related articles for article (PubMed ID: 31275312)
1. Divergent Effects of Acute and Prolonged Interleukin 33 Exposure on Mast Cell IgE-Mediated Functions.
Rönnberg E; Ghaib A; Ceriol C; Enoksson M; Arock M; Säfholm J; Ekoff M; Nilsson G
Front Immunol; 2019; 10():1361. PubMed ID: 31275312
[No Abstract] [Full Text] [Related]
2. Thymic stromal lymphopoietin-induced interleukin-17A is involved in the development of IgE-mediated atopic dermatitis-like skin lesions in mice.
Mizutani N; Sae-Wong C; Kangsanant S; Nabe T; Yoshino S
Immunology; 2015 Dec; 146(4):568-81. PubMed ID: 26310839
[TBL] [Abstract][Full Text] [Related]
3. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
[TBL] [Abstract][Full Text] [Related]
4. Activation of Human Basophils by A549 Lung Epithelial Cells Reveals a Novel IgE-Dependent Response Independent of Allergen.
Schroeder JT; Bieneman AP
J Immunol; 2017 Aug; 199(3):855-865. PubMed ID: 28652400
[TBL] [Abstract][Full Text] [Related]
5. Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways.
Akasaki S; Matsushita K; Kato Y; Fukuoka A; Iwasaki N; Nakahira M; Fujieda S; Yasuda K; Yoshimoto T
Int Immunol; 2016 Feb; 28(2):65-76. PubMed ID: 26428949
[TBL] [Abstract][Full Text] [Related]
6. IL-33 and Thymic Stromal Lymphopoietin in mast cell functions.
Saluja R; Zoltowska A; Ketelaar ME; Nilsson G
Eur J Pharmacol; 2016 May; 778():68-76. PubMed ID: 26051792
[TBL] [Abstract][Full Text] [Related]
7. AGK2 ameliorates mast cell-mediated allergic airway inflammation and fibrosis by inhibiting FcεRI/TGF-β signaling pathway.
Kim YY; Hur G; Lee SW; Lee SJ; Lee S; Kim SH; Rho MC
Pharmacol Res; 2020 Sep; 159():105027. PubMed ID: 32565308
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole inhibits IgE-mediated mast cell activation and allergic inflammation induced by ingested allergen in mice.
Kanagaratham C; El Ansari YS; Sallis BF; Hollister BA; Lewis OL; Minnicozzi SC; Oyoshi MK; Rosen R; Nurko S; Fiebiger E; Oettgen HC
J Allergy Clin Immunol; 2020 Oct; 146(4):884-893.e5. PubMed ID: 32194041
[TBL] [Abstract][Full Text] [Related]
9. Loss of SOCS7 in mice results in severe cutaneous disease and increased mast cell activation.
Knisz J; Banks A; McKeag L; Metcalfe DD; Rothman PB; Brown JM
Clin Immunol; 2009 Aug; 132(2):277-84. PubMed ID: 19427817
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 selectively enhances the IgE-mediated production of IL-6 and granulocyte-macrophage colony-stimulating factor by mast cells through an EP1/EP3-dependent mechanism.
Gomi K; Zhu FG; Marshall JS
J Immunol; 2000 Dec; 165(11):6545-52. PubMed ID: 11086097
[TBL] [Abstract][Full Text] [Related]
11. Regulation of IgE-dependent zinc release from human mast cells.
Nakashima-Kaneda K; Matsuda A; Mizuguchi H; Sasaki-Sakamoto T; Saito H; Ra C; Okayama Y
Int Arch Allergy Immunol; 2013; 161 Suppl 2():44-51. PubMed ID: 23711853
[TBL] [Abstract][Full Text] [Related]
12. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
[TBL] [Abstract][Full Text] [Related]
13. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide suppresses IgE-mast cell-mediated reactions.
Wang N; McKell M; Dang A; Yamani A; Waggoner L; Vanoni S; Noah T; Wu D; Kordowski A; Köhl J; Hoebe K; Divanovic S; Hogan SP
Clin Exp Allergy; 2017 Dec; 47(12):1574-1585. PubMed ID: 28833704
[TBL] [Abstract][Full Text] [Related]
15. IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors.
Cristinziano L; Poto R; Criscuolo G; Ferrara AL; Galdiero MR; Modestino L; Loffredo S; de Paulis A; Marone G; Spadaro G; Varricchi G
Cells; 2021 Jan; 10(1):. PubMed ID: 33445787
[TBL] [Abstract][Full Text] [Related]
16. Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses.
Sumpter TL; Ho CH; Pleet AR; Tkacheva OA; Shufesky WJ; Rojas-Canales DM; Morelli AE; Larregina AT
J Allergy Clin Immunol; 2015 Apr; 135(4):1019-1030.e8. PubMed ID: 25201259
[TBL] [Abstract][Full Text] [Related]
17. Tafazzin Modulates Allergen-Induced Mast Cell Inflammatory Mediator Secretion.
Maguire ARR; Crozier RWE; Hunter KD; Claypool SM; Fajardo VA; LeBlanc PJ; MacNeil AJ
Immunohorizons; 2021 Apr; 5(4):182-192. PubMed ID: 33895725
[TBL] [Abstract][Full Text] [Related]
18. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
[TBL] [Abstract][Full Text] [Related]
19. IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62.
Ball DH; Al-Riyami L; Harnett W; Harnett MM
Sci Rep; 2018 Mar; 8(1):4497. PubMed ID: 29540770
[TBL] [Abstract][Full Text] [Related]
20. Differential TLR-induced cytokine production by human mast cells is amplified by FcɛRI triggering.
Suurmond J; Dorjée AL; Knol EF; Huizinga TW; Toes RE
Clin Exp Allergy; 2015 Apr; 45(4):788-96. PubMed ID: 25665021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
